SEARCH

SEARCH BY CITATION

References

  • Andersson M., Konradi C. and Cenci M. A. (2001) cAMP response element-binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-denervated striatum. J. Neurosci. 21, 993043.
  • Baker S. A., Baker K. A. and Hagg T. (2004) Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone. Eur. J. Neurosci. 20, 575579.
  • Borta A. and Hoglinger G. U. (2007) Dopamine and adult neurogenesis. J. Neurochem. 100, 587595.
  • Bouthenet M. L., Souil E., Martres M. P., Sokoloff P., Giros B. and Schwartz J. C. (1991) Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564, 203219.
  • Bruel-Jungerman E., Rampon C. and Laroche S. (2007) Adult hippocampal neurogenesis, synaptic plasticity and memory: facts and hypotheses. Rev. Neurosci. 18, 93114.
  • Bruel-Jungerman E., Lucassen P. J. and Francis F. (2011) Cholinergic influences on cortical development and adult neurogenesis. Behav. Brain Res. 221, 379388.
  • Chourbaji S., Brandwein C., Vogt M. A., Dormann C., Mueller R., Drescher K. U., Gross G. and Gass P. (2008) Dopamine receptor 3 (D3) knockout mice show regular emotional behaviour. Pharmacol. Res. 58, 302307.
  • Coronas V., Bantubungi K., Fombonne J., Krantic S., Schiffmann S. N. and Roger M. (2004) Dopamine D3 receptor stimulation promotes the proliferation of cells derived from the post-natal subventricular zone. J. Neurochem. 91, 12921301.
  • Couillard-Despres S., Winner B., Schaubeck S., Aigner R., Vroemen M., Weidner N., Bogdahn U., Winkler J., Kuhn H.-G. and Aigner L. (2005) Doublecortin expression levels in adult brain reflect neurogenesis. Eur. J. Neurosci. 21, 114.
  • Deng W., Aimone J. B. and Gage F. H. (2010) New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory? Nat. Rev. Neurosci. 11, 339350.
  • Egeland M., Warner-Schmidt J., Greengard P. and Svenningsson P. (2010) Neurogenic effects of fluoxetine are attenuated in p11 (S100A10) knockout mice. Biol. Psychiatry 67, 10481056.
  • Le Foll B., Diaz J. and Sokoloff P. (2005) Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice. Life Sci. 76, 12811296.
  • Freundlieb N., Francois C., Tande D., Oertel W. H., Hirsch E. C. and Hoglinger G. U. (2006) Dopaminergic substantia nigra neurons project topographically organized to the subventricular zone and stimulate precursor cell proliferation in aged primates. J. Neurosci. 26, 23212325.
  • Hagg T. (2009) From neurotransmitters to neurotrophic factors to neurogenesis. Neuroscientist 15, 2027.
  • Heintz N. (2004) Gene expression nervous system atlas (GENSAT). Nat. Neurosci. 7, 483.
  • Hoglinger G. U., Rizk P., Muriel M. P., Duyckaerts C., Oertel W. H., Caille I. and Hirsch E. C. (2004) Dopamine depletion impairs precursor cell proliferation in Parkinson disease. Nat. Neurosci. 7, 726735.
  • Joseph J. D., Wang Y.-M., Miles P. R., Budygin E., a, Picetti, R., Gainetdinov, R. R., Caron, M. G. et al. (2002) Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience 112, 3949.
  • Joyce J. N. and Millan M. J. (2007) Dopamine D3 receptor agonists for protection and repair in Parkinson's disease. Curr. Opin. Pharmacol. 7, 100105.
  • Van Kampen J. M., Hagg T. and Robertson H. A. (2004) Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation. Eur. J. Neurosci. 19, 23772387.
  • Kee N., Sivalingam S., Boonstra R. and Wojtowicz J. M. (2002) The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis. J. Neurosci. Methods 115, 97105.
  • Kim Y., Wang W. Z., Comte I. et al. (2010) Dopamine stimulation of postnatal murine subventricular zone neurogenesis via the D3 receptor. J. Neurochem. 114, 750760.
  • Kippin T. E., Kapur S. and van der Kooy D. (2005) Dopamine specifically inhibits forebrain neural stem cell proliferation, suggesting a novel effect of antipsychotic drugs. J. Neurosci. 25, 58155823.
  • Koeltzow T. E., Xu M., Cooper D. C., Hu X. T., Tonegawa S., Wolf M. E. and White F. J. (1998) Alterations in dopamine release but not dopamine autoreceptor function in dopamine D3 receptor mutant mice. J. Neurosci. 18, 22318.
  • Kottmann A. H., Verbitsky M., Perez M. and Gonzales L. E. (2011) Sonic Hedgehog (Shh) expression by neurons acts as sentinel for tissue dysfunction and regulates cell fate determination in somatic stem cell niches. Society for Neuroscience, Washington DC, Poster no. 529.08.
  • Lacroix L. P., Ceolin L., Zocchi A., Varnier G., Garzotti M., Curcuruto O. and Heidbreder C. A. (2006) Selective dopamine D3 receptor antagonists enhance cortical acetylcholine levels measured with high-performance liquid chromatography/tandem mass spectrometry without anticholinesterases. J. Neurosci. Methods 157, 2531.
  • Laszy J., Laszlovszky I. and Gyertyan I. (2005) Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats. Psychopharmacology 179, 567575.
  • Leggio G. M., Micale V. and Drago F. (2008) Increased sensitivity to antidepressants of D3 dopamine receptor-deficient mice in the forced swim test (FST). Eur. Neuropsychopharmacol. 18, 271277.
  • Lucassen P. J., Meerlo P., Naylor A., Svan Dam A. M., Dayer A. G., Fuchs E., Oomen C. A. and Czéh B. (2010) Regulation of adult neurogenesis by stress, sleep disruption, exercise and inflammation: implications for depression and antidepressant action. Eur. Neuropsychopharmacol. 20, 117.
  • Malberg J. E., Eisch A. J., Nestler E. J. and Duman R. S. (2000) Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J. Neurosci. 20, 91049110.
  • Mannoury la Cour C., Salles M. J., Pasteau V. and Millan M. J. (2011) Signaling pathways leading to phosphorylation of Akt and GSK-3beta by activation of cloned human and rat cerebral Dand D receptors. Mol. Pharmacol. 79, 91105.
  • McClung C. A., Ulery P. G., Perrotti L. I., Zachariou V., Berton O. and Nestler E. J. (2004) DeltaFosB: a molecular switch for long-term adaptation in the brain. Brain Res. Mol. Brain Res. 132, 146154.
  • Micale V., Cristino L., Tamburella A., Petrosino S., Leggio G. M., Di Marzo V. and Drago F. (2010) Enhanced cognitive performance of dopamine D3 receptor “knock-out” mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems. Pharmacol. Res. 61, 531536.
  • Millan M. J. and Brocco M. (2008) Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the optimised D(3) > D(2) antagonist, S33138. Therapie 63, 187229.
  • Millan M. J., Mannoury la Cour C., Novi F. et al. (2008a) S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: i. Receptor-binding profile and functional actions at G-protein-coupled receptors. J. Pharmacol. Exp. Ther. 324, 587599.
  • Millan M. J., Svenningsson P., Ashby C. R., Jr et al. (2008b) S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo. J. Pharmacol. Exp. Ther. 324, 600611.
  • Millan M. J., Loiseau F., Dekeyne A. et al. (2008c) S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects. J. Pharmacol. Exp. Ther. 324, 12121226.
  • Millan M. J., Buccafusco J. J., Loiseau F. et al. (2010) The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. Int. J. Neuropsychopharmacol. 13, 10351051.
  • Millan M. J., Agid Y., Brüne M. et al. (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat. Rev. Drug Discov. 11, 141168.
  • Mu Y., Zhao C. and Gage F. H. (2011) Dopaminergic modulation of cortical inputs during maturation of adult-born dentate granule cells. J. Neurosci. 31, 41134123.
  • O'Keeffe G. C., Tyers P., Aarsland D., Dalley J. W., Barker R. A. and Caldwell M. A. (2009) Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF. Proc. Natl Acad. Sci. USA 106, 87548759.
  • Park J. H. and Enikolopov G. (2010) Transient elevation of adult hippocampal neurogenesis after dopamine depletion. Exp. Neurol. 222, 267276.
  • Peng J., Xie L., Jin K., Greenberg D. A. and Andersen J. K. (2008) Fibroblast growth factor 2 enhances striatal and nigral neurogenesis in the acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Neuroscience 153, 664670.
  • Petrik D., Lagace D. C. and Eisch A. J. (2012) The neurogenesis hypothesis of affective and anxiety disorders: are we mistaking the scaffolding for the building? Neuropharmacology 62, 2134.
  • Robertson G. S., Lee C. J., Sridhar K., Nakabeppu Y., Cheng M., Wang Y. M. and Caron M. G. (2004) Clozapine-, but not haloperidol-, induced increases in deltaFosB-like immunoreactivity are completely blocked in the striatum of mice lacking D3 dopamine receptors. Eur. J. Neurosci. 20, 31893194.
  • Sairanen M., Lucas G., Ernfors P., Castrén M. and Castrén E. (2005) Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J. Neurosci. 25, 10891094.
  • Sokoloff P., Diaz J., Le Foll B., Guillin O., Leriche L., Bezard E. and Gross C. (2006) The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. CNS Neurol. Disord. Drug Targets 5, 2543.
  • Vialou V., Feng J., Robison A. J., Ku S. M., Ferguson D., Scobie K. N., Mazei-Robison M. S. et al. (2012) Serum Response Factor and cAMP Response Element Binding Protein Are Both Required for Cocaine Induction of {Delta}FosB. J. Neurosci. 32, 75777584.
  • Xing B., Meng X., Wei S. and Li S. (2010) Influence of dopamine D3 receptor knockout on age-related decline of spatial memory. Neurosci. Lett. 481, 149153.
  • Yang P., Arnold S. A., Habas A., Hetman M. and Hagg T. (2008) Ciliary neurotrophic factor mediates dopamine D-2 receptor-induced CNS neurogenesis in adult mice. J. Neurosci. 28, 22312241.
  • Zapata A., Witkin J. M. and Shippenberg T. S. (2001) Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses. Neuropharmacol 41, 351359.